TUCALIV 50MG TABLET

Form: Tablets

Pack Size: 60 TABLETS

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹13234.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Tucaliv 50MG Tablet, 60 tablets, salt tucatinib 50mg. NPPA has revised its MRP from Rs 19,300 to Rs 13,234 (31% lower) with effect from 09-11-2026; trade rate Rs 10,083.05. Group: HER2 tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by MSN. Handling/counselling: given with trastuzumab and capecitabine; check the full regimen. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.